Reuters logo
BRIEF-VBI Vaccines announces phase 3 clinical program for Sci-B-Vac(TM) Hepatitis B vaccine
2017年7月11日 / 晚上8点20分 / 4 个月前

BRIEF-VBI Vaccines announces phase 3 clinical program for Sci-B-Vac(TM) Hepatitis B vaccine

July 11 (Reuters) - VBI Vaccines Inc

* VBI Vaccines announces phase 3 clinical program for Sci-B-Vac(TM) Hepatitis B vaccine

* VBI Vaccines Inc - ‍phase 3 program will be conducted at approximately 40 sites across U.S., Europe, and Canada​

* VBI Vaccines Inc - Anticipate initiating enrollment in both phase 3 studies in second half of 2017

* VBI Vaccines Inc - ‍Phase 3 program will be a global 15-month program and will consist of two concurrent phase 3 studies​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below